![Cancers | Free Full-Text | Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy Cancers | Free Full-Text | Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy](https://www.mdpi.com/cancers/cancers-14-05445/article_deploy/html/images/cancers-14-05445-g001-550.jpg)
Cancers | Free Full-Text | Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
![Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma](https://www.frontiersin.org/files/Articles/561200/fimmu-11-01941-HTML-r1/image_m/fimmu-11-01941-g001.jpg)
Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
![15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges - Chatterjee ... 15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges - Chatterjee ...](https://onlinelibrary.wiley.com/cms/asset/5b383152-ecc4-449a-80f9-793cd22b93c4/ejh14102-fig-0001-m.jpg)
15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges - Chatterjee ...
![B‐lineage antigens that are useful to substitute CD19 for minimal residual disease monitoring in B cell precursor acute lymphoblastic leukemia after CD19 targeting - Mikhailova - 2022 - Cytometry Part B: Clinical B‐lineage antigens that are useful to substitute CD19 for minimal residual disease monitoring in B cell precursor acute lymphoblastic leukemia after CD19 targeting - Mikhailova - 2022 - Cytometry Part B: Clinical](https://onlinelibrary.wiley.com/cms/asset/c98275a6-59c2-4e17-a463-b9f0bd26ab7b/cytob22088-fig-0003-m.jpg)
B‐lineage antigens that are useful to substitute CD19 for minimal residual disease monitoring in B cell precursor acute lymphoblastic leukemia after CD19 targeting - Mikhailova - 2022 - Cytometry Part B: Clinical
![Ingranaggio di ingresso e uscita del ponte per MARANTZ CD17 CD19 una puleggia di ingresso e uscita del movimento - AliExpress Ingranaggio di ingresso e uscita del ponte per MARANTZ CD17 CD19 una puleggia di ingresso e uscita del movimento - AliExpress](https://ae01.alicdn.com/kf/H7b02eb76d0ad4d0eabb85d83b530f16bi/Ingranaggio-di-ingresso-e-uscita-del-ponte-per-MARANTZ-CD17-CD19-una-puleggia-di-ingresso-e.jpg)
Ingranaggio di ingresso e uscita del ponte per MARANTZ CD17 CD19 una puleggia di ingresso e uscita del movimento - AliExpress
Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells | Haematologica
The defect of B cell development in CD19-Cre + PDK1 flox/flox mice is... | Download Scientific Diagram
![Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India | Bone Marrow Transplantation Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India | Bone Marrow Transplantation](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41409-022-01866-5/MediaObjects/41409_2022_1866_Figa_HTML.png)
Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India | Bone Marrow Transplantation
![Reduced peripheral blood regulatory B cell levels are not associated with the Expanded Disability Status Scale score in multiple sclerosis - Shujun Guo, Qingqing Chen, Xiaoli Liang, Mimi Mu, Jing He, Qiang Reduced peripheral blood regulatory B cell levels are not associated with the Expanded Disability Status Scale score in multiple sclerosis - Shujun Guo, Qingqing Chen, Xiaoli Liang, Mimi Mu, Jing He, Qiang](https://journals.sagepub.com/cms/10.1177/0300060518783083/asset/images/large/10.1177_0300060518783083-fig2.jpeg)
Reduced peripheral blood regulatory B cell levels are not associated with the Expanded Disability Status Scale score in multiple sclerosis - Shujun Guo, Qingqing Chen, Xiaoli Liang, Mimi Mu, Jing He, Qiang
![Incyte e MorphoSys raggiungono la cooperazione per sviluppare Tafasitamab anticorpo monoclonale mirato a CD19 per il trattamento dei tumori delle cellule B! - Notizie del settore - Notizie - Hefei Home Sunshine Incyte e MorphoSys raggiungono la cooperazione per sviluppare Tafasitamab anticorpo monoclonale mirato a CD19 per il trattamento dei tumori delle cellule B! - Notizie del settore - Notizie - Hefei Home Sunshine](http://it.hspchem.com/Content/uploads/2020524038/202001151200363816506.png)
Incyte e MorphoSys raggiungono la cooperazione per sviluppare Tafasitamab anticorpo monoclonale mirato a CD19 per il trattamento dei tumori delle cellule B! - Notizie del settore - Notizie - Hefei Home Sunshine
![Bone marrow cells of CD19-Cre+PDK1+/+ and CD19-Cre+PDK1flox/flox mice... | Download Scientific Diagram Bone marrow cells of CD19-Cre+PDK1+/+ and CD19-Cre+PDK1flox/flox mice... | Download Scientific Diagram](https://www.researchgate.net/publication/235423484/figure/fig3/AS:213997228957698@1428032323296/Bone-marrow-cells-of-CD19-Cre-PDK1-and-CD19-Cre-PDK1flox-flox-mice-were-transferred.png)
Bone marrow cells of CD19-Cre+PDK1+/+ and CD19-Cre+PDK1flox/flox mice... | Download Scientific Diagram
![Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production | Protocol (Translated to Italian) Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production | Protocol (Translated to Italian)](https://www.jove.com/files/ftp_upload/61003/61003fig02large.jpg)